# A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B

> **NCT01887275** · PHASE4 · COMPLETED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 439 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DEVICE:** medical ozone therapy with humares
- **DRUG:** conventional interferon-α

## Key facts

- **NCT ID:** NCT01887275
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 439 (ACTUAL)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01887275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01887275, "A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01887275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*